Stephan O. Krause, PhD, is a biopharmaceutical quality and analytical science leader with over two decades of experience advancing global standards across biologics, cell therapies, and analytical control strategies. As Executive Director for Analytical Strategy at Bristol Myers Squibb, he leads analytical strategy development and lifecycle execution for cell therapy products across global sites. Stephan has received more than a dozen awards for his publications and industry leadership. He is a member of multiple advisory boards and chairs industry task forces, such as Phase-Appropriate QMS for ATMPs and ANS-07 Analytical Standard Development.